research use only

Sec31A Antibody [J15M23]

Cat.No.: F8573

    Application: Reactivity:
    • F8573-wb
      Lane 1: MCF7, Lane 2: SKOV-3, Lane 3: K562

    Usage Information

    Dilution
    1:1000
    1:400
    Application
    WB, IF
    Reactivity
    Human, Mouse, Rat, Monkey
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    95-140 kDa

    Datasheet & SDS

    Biological Description

    Specificity
    Sec31A Antibody [J15M23] detects endogenous levels of total Sec31A protein.
    Clone
    J15M23
    Synonym(s)
    Protein transport protein Sec31A; SEC31A
    Background
    Sec31A is a core subunit of the coat protein complex II (COPII), a multimeric coat that mediates the formation of transport vesicles at the interface between the endoplasmic reticulum and the Golgi apparatus. Sec31A forms a β‑propeller WD‑repeat domain that interacts with Sec13 and self‑assembles into flexible, cage‑like scaffolds that physically shape budding COPII vesicles and simultaneously stimulate the GTPase activity of the Sar1–Sec23/24 inner coat complex, thereby coordinating the recruitment, deformation, and fission of ER‑derived carriers. Sec31A also contains a proline‑rich C‑terminal region that binds regulatory proteins and calcium‑sensing factors such as ALG‑2 and annexin‑A11, enabling luminal–cytosolic crosstalk and Ca²⁺‑dependent modulation of coat stability and vesicle‑budding kinetics, and its ubiquitously expressed isoform contrasts with the more restricted Sec31B paralog, whose expression peaks in brain and testis. Sec31A helps couple COPII assembly to ER‑export signals, ensuring that nascent secretory and membrane proteins are packaged into ER‑to‑Golgi carriers, and disruption of Sec31A function delays cargo exit, perturbs ER‑Golgi trafficking, and impairs secretion and cell‑surface delivery. Chromosomal rearrangements generate an SEC31A–JAK2 fusion that drives constitutive JAK2 kinase activity and downstream STAT‑dependent signaling, rendering cells sensitive to JAK inhibitors.
    References
    • https://pubmed.ncbi.nlm.nih.gov/21325169/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.